Steroid therapy of septic shock: The decision is in the eye of the beholder

Critical Care Medicine

Volumn 36, Issue 6, 2008, Pages 1987-1989

  Dellinger, R Phillip ^a  

^a Division of Genetics Cooper Medical School of Rowan University Cooper University Health Care 3   (United States)

Author keywords

Acute respiratory distress syndrome; Corticosteroid; Critical care; Intensive care; Sepsis

Indexed keywords

CORTICOSTEROID; HYDROCORTISONE; HYPERTENSIVE AGENT; NORADRENALIN; STEROID; ANTIINFLAMMATORY AGENT; METHYLPREDNISOLONE; VASOCONSTRICTOR AGENT;

ADRENAL INSUFFICIENCY; ADULT RESPIRATORY DISTRESS SYNDROME; BLOOD PRESSURE; CLINICAL PROTOCOL; CLINICAL TRIAL; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DISEASE SEVERITY; EDITORIAL; FLUID RESUSCITATION; HUMAN; INTENSIVE CARE; PRIORITY JOURNAL; SEPTIC SHOCK; STEROID THERAPY; SURVIVAL; TREATMENT RESPONSE; DECISION SUPPORT SYSTEM; FLUID THERAPY; INTRAVENOUS DRUG ADMINISTRATION; MULTIMODALITY CANCER THERAPY; NOTE; PROGNOSIS;

ADRENAL INSUFFICIENCY; ANTI-INFLAMMATORY AGENTS; COMBINED MODALITY THERAPY; CRITICAL CARE; DECISION SUPPORT TECHNIQUES; FLUID THERAPY; HUMANS; HYDROCORTISONE; INFUSIONS, INTRAVENOUS; METHYLPREDNISOLONE; PROGNOSIS; RESPIRATORY DISTRESS SYNDROME, ADULT; SHOCK, SEPTIC; VASOCONSTRICTOR AGENTS;

EID: 45149084684     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31817d7ee4     Document Type: Editorial

References (20)

1. Waterhouse R: A case of suprarenal apoplexy. Lancet 1911; I:577-578
2. Meduri GU: An historical review of glucocor-ticoid treatment in sepsis. Disease patho-physiology and the design of treatment investigation. Sepsis 1999; 3:21-38
3. Perla D, Marmorston J: Suprarenal cortical hormone and salt in the treatment of pneumonia and other severe infections. Endocrinology 1940; 27:367-374
4. Kinsell LW, Jahn JP: The use of corticoids in association with antibiotics in the management of unusually severe infections. Ann NY Acad Sci 1955; 61:397-407
5. Breen GE, Talukdar PK: Corticosteroids in acute infections. Lancet 1965; 1:158-160
6. Motsay GJ, Alho A, Jaeger T, et al: Effects of corticosteroids on the circulation in shock: experimental and clinical results. Fed Proc 1970; 29:1861-1873
7. Schumer W: Steroids in the treatment of clinical septic shock. Ann Surg 1976; 184:333-339
8. Bone RC, Fisher CJ, Clemmer TP, et al: A controlled clinical trial of high dose methyl prednisolone in the treatment of severe sepsis and septic shock. N Engl J Medt 1987; 317:653-658
9. The Veterans Administration Systemic Sepsis Cooperative Study Group: Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Medt 1987; 317:659-665
10. Scheinman RI, Cogswell PC, Lofquist AK, et al: Role of transcriptional activation of IkBa in medication of immunosuppression by glu-cocorticoids. Science 1995; 270:283-290
11. Bollaert PE, Charpentier C, Levy B, et al: Reversal of late septic shock with supraphysi-ologic doses of hydrocortisone. Crit Care Med 1998; 26:645-650
12. Briegel J, Forst H, Haller M, et al: Stress doses of hydrocortisone reverse hyperdy-namic septic shock: A perspective, randomized, double-blind, single-center study. Crit Care Med 1999; 27:723-732
13. Meduri GU, Headley S, Golden E, et al: Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome. A randomized controlled trial. JAMA 1998; 280:159-165
14. Annane D, Sebille V, Charpentier C, et al: Effect of treatment with low doses of hydro-cortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288: 862-871
15. Sprung CL, Annane D, Briegel J, et al: Corti-costeroid therapy of septic shock (CORTICUS). Abstr. Am Rev Respir Crit Care Med 2007; 175:A507
16. Marik PE, Pastores SM, Annane D, et al: Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: Consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 2008; 36:1937-1949
17. Dellinger RP, Levy MM, Carlet JM, et al: Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock. Crit Care Med 2008; 36: 296-327
18. The Acute Respiratory Distress Syndrome Network: Efficacy and safety of corticoste-roids for persistent acute respiratory distress syndrome. N Engl J Medt 2006; 354: 1671-1684
19. Confalonieri M, Urbino R, Potena A, et al: Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med 2005; 171:242-248
20. Meduri GU, Golden E, Freire AX, et al: Meth-ylprednisolone infusion in patients with early severe ARDS: results of randomized trial. Chest 2007; 131:954-963